Skip to main content
Lasa Supergenerics Limited logo

Lasa Supergenerics Limited — Investor Relations & Filings

Ticker · LASA ISIN · INE670X01014 LEI · 984500B9EA5EC3R2F726 BSE.NS Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2025-01-22 Regulatory Filings
Country IN India
Listing BSE.NS LASA

About Lasa Supergenerics Limited

https://lasalabs.com/

Lasa Supergenerics Limited is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs) for both veterinary and human health applications. The company focuses on the research, development, and production of high-quality chemical intermediates and APIs. Its core product portfolio includes a significant range of anthelmintics, such as Albendazole, Fenbendazole, and Ricobendazole, alongside other specialized therapeutic categories. Utilizing advanced manufacturing facilities and a dedicated research and development wing, the organization emphasizes cost-effective production processes and stringent quality control standards. Lasa Supergenerics Limited serves a global clientele, providing essential components for pharmaceutical formulations and animal health products through its expertise in complex chemical synthesis and large-scale manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-22 English
Board Meeting — Fund Raising
Board/Management Information Classification · 95% confidence The document is a notice of a scheduled Board Meeting, specifically informing stock exchanges about the upcoming meeting where the board will consider and approve fundraising activities such as issuance of warrants and equity shares. It is an intimation of a board meeting rather than the meeting minutes or any detailed report. The content aligns with announcements related to board or management activities, particularly about corporate decisions. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and does not contain financial data or detailed reports, so it is not an Annual Report or Capital/Financing Update report itself, but a notice about board decisions related to capital raising.
2025-01-22 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the cancellation of a scheduled Board Meeting. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, which pertains to disclosures related to board meetings. The content is an announcement about a change in the board meeting schedule, not a report or detailed information about board or management changes themselves. The document length is only 1398 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-22 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued for the quarter ended December 31, 2024. It is a compliance certificate from the Registrar and Share Transfer Agent confirming dematerialization and listing of securities. The document is addressed to stock exchanges and is a formal attestation rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. The document length is 3232 characters, which is relatively short and consistent with a certification or regulatory filing. Therefore, it fits the category of Regulatory Filings (RNS) as it is a regulatory compliance certificate rather than a report or announcement of financial results or corporate actions.
2025-01-20 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-20 English
Board Meeting — Fund Raising
Board/Management Information Classification · 95% confidence The document is a formal notice titled 'Board Meeting Intimation' addressed to stock exchanges, indicating a scheduled meeting of the Board of Directors. It mentions agenda items related to the issue of warrants and approval of a draft notice for an Extraordinary General Meeting. The document references compliance with SEBI regulations and provides details about the meeting date and agenda. The document length is 1911 characters, which is relatively short and does not contain any financial statements or detailed financial data. It is an announcement about a board meeting and related corporate actions, not a full report or financial filing. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or meetings involving the company's board or senior management.
2025-01-20 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.